Gene Therapy for Liver Cancer Using Ultrasound and Microbubbles
Author Information
Author(s): Zhou Shiji, Li Shengwei, Liu Zuojin, Tang Yong, Wang Zhigang, Gong Jianping, Liu Changan
Primary Institution: The Second Affiliated Hospital of Chongqing Medical University
Hypothesis
Can ultrasound-targeted microbubble destruction effectively deliver the HSV-TK gene to treat hepatoma in mice?
Conclusion
Ultrasound-targeted microbubble destruction can effectively transfect the HSV-TK gene into target tissues and significantly inhibit tumors, providing a new strategy for gene therapy in liver cancer.
Supporting Evidence
- The HSV-TK+US+MB group showed significantly higher TK protein expression compared to other groups.
- Ultrasound-targeted microbubble destruction significantly improved the survival time of tumor-bearing mice.
- The tumor inhibition rate was highest in the HSV-TK+US+MB group at 41.25%.
Takeaway
This study shows that using sound waves and tiny bubbles can help deliver a special gene to fight liver cancer in mice.
Methodology
Forty mice were divided into four groups and treated with different combinations of HSV-TK gene and ultrasound with microbubbles, followed by analysis of tumor growth and survival.
Potential Biases
Potential bias in the selection of treatment groups and measurement of outcomes.
Limitations
The study was conducted on mice, and results may not directly translate to humans.
Participant Demographics
40 male Kunming mice, aged 6 to 8 weeks, weighing 20 ± 2 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website